The effects of selective and nonselective phosphodiesterase inhibitors on phagocytic cells in mice

References

• Bender AT, Beavo JA. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use. Pharmacol Rev 2006; 58(3):488–520.
   PubMed Web of Science ®Google Scholar
• Burnouf C, Pruniaux MP. Recent advances in PDE4 inhibitors as immunoregulators and anti-inflammatory drugs. Curr Pharm Des 2002; 8(14):1255–1296.
   PubMed Web of Science ®Google Scholar
• Torphy TJ. Phosphodiesterase isozymes. Molecular targets for novel antiasthma agents. Am J Respir Crit Care Med 1998; 157(2):351–370.
   PubMed Web of Science ®Google Scholar
• Dal Piaz V., Giovannoni MP. Phosphodiesterase 4 inhibitors, structurally unrelated to rolipram, as promising agents for the treatment of asthma and other pathologies. Eur J Med Chem 2000; 35(5):463–480.
   PubMed Web of Science ®Google Scholar
• Dyke HJ. Montana, JG. Update on the therapeutic potential of PDE4 inhibitors. Expert Opin Investig Drugs 2002; 11(1):1–13.
   PubMed Web of Science ®Google Scholar
• Banner KH, Page CP. Immunomodulatory actions of xanthines and isoenzyme selective phosphodiesterase inhibitors. Monaldi Arch Chest Dis 1995; 50(4):286–292.
   PubMedGoogle Scholar
• Beshay E, Croze F, Prud’homme GJ. The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage activation and nitric oxide production in vitro and in vivo. Clin Immunol 2001; 98(2):272–279.
   PubMed Web of Science ®Google Scholar
• Kambayashi T, Jacob CO, Zhou D, Mazurek N, Fong M, Strassmann G. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages. J Immunol 1995; 155(10):4909–4916.
   PubMed Web of Science ®Google Scholar
• Rieneck K, Diamant M, Haahr P-M, Schonharting M, Bendtzen K. In vitro immunomodulatory effects of pentoxifylline. Immunol Lett 1993; 37(2–3):131–138.
   PubMed Web of Science ®Google Scholar
• Spina D, Landells LJ, Page CP. The role of theophylline and phosphodiesterase4 isoenzyme inhibitors as anti-inflammatory drugs. Clin Exp Allergy 1998; 28(Suppl 3):24–34.
   PubMedGoogle Scholar
• Zabel P, Schade FU, Schlaak M. Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 1993; 187(3–5):447–463.
   PubMed Web of Science ®Google Scholar
• Mikawa K, Akamatsu H, Nishina K, Shiga M, Maekawa N, Obara H, et al. The effect of phosphodiesterase III inhibitors on human neutrophil function. Crit Care Med 2000; 28(4):1001–1005.
   PubMed Web of Science ®Google Scholar
• Molnar-Kimber K, Yonno L, Heaslip R, Weichman B. Modulation of TNF-α and IL-1β from endotoxin-stimulated monocytes by selective PDE isozyme inhibitors. Agents Actions 1993; 39 Spec No:C77–C79.
   Google Scholar
• Nielson CP, Vestal RE, Sturm RJ, Heaslip R. Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J Allergy Clin Immunol 1990; 86(5):801–808.
   PubMed Web of Science ®Google Scholar
• Toward TJ, Smith N, Broadley KJ. Effect of phosphodiesterase-5 inhibitor, sildenafil (viagra), in animal models of airways disease. Am J Respir Crit Care Med 2004; 169(2):227–234.
   PubMed Web of Science ®Google Scholar
• Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985; 82(22):7738–7742.
   PubMed Web of Science ®Google Scholar
• Tenor H, Hatzelmann A, Kupferschmidt R, Stanciu L, Djukanowic R, Schudt C, et al.. Cyclic nucleotide phosphodiesterase isoenzyme activities in human alveolar macrophages. Clin Exp Allergy 1995; 25(7):625–633.
   PubMed Web of Science ®Google Scholar
• Gantner F, Kupferschmidt R, Schudt C, Wendel A, Hatzelmann A. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors. Br J Pharmacol 1997; 121(2):221–231.
   PubMed Web of Science ®Google Scholar
• Nemeth ZH, Szabo C, Hasko G, Salzman AL, Vizi ES. Effect of the phosphodiesterase III inhibitor amrinone on cytokine and nitric oxide production in immunostimulated J774.1 macrophages. Eur J Pharmacol 1997; 339(2–3):215–231.
   PubMed Web of Science ®Google Scholar
• Verghese MW, McConnell RT, Strickland AB, Gooding RC, Stimpson SA, Yarnall DP, et al. Differential regulation of human monocyte-derived TNF alpha and IL-1 beta by type IV cAMP-phosphodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 1995; 272(3):1313–1320.
   PubMed Web of Science ®Google Scholar
• Yoshimura T, Kurita C, Nagao T, Usami E, Nakao T, Watanabe S, et al. Effects of cAMP-phosphodiesterase isozyme inhibitor on cytokine production by lipopolysaccharide-stimulated human peripheral blood mononuclear cells. Gen Pharmacol 1997; 29(4):633–638.
   PubMedGoogle Scholar
• Haddad JJ, Land SC, Tarnow-Mordi WO, Zembala M, Kowalczyk D, Lauterbach R. Immunopharmacological potential of selective phosphodiesterase inhibition. I. Differential regulation of lipopolysaccharide-mediated proinflammatory cytokine (interleukin-6 and tumor necrosis factor-alpha) biosynthesis in alveolar epithelial cells. J Pharmacol Exp Ther 2002; 300(2):559–566.
   PubMed Web of Science ®Google Scholar
• Masaki Y, Sato W, Kayaba M, Enzan K, Suzuki M. Milrinone suppresses TNF-alpha and IL–1 beta release in mouse peritoneal macrophages. [in Japanese]. Masui 1995; 44(6):800–804.
   PubMedGoogle Scholar
• Nemeth ZH, Hasko G, Szabo C, Vizi ES. Amrinone and teophylline differentially regulate cytokine and nitric oxide production in endotoxemic mice. Shock 1997; 7(5):371–375.
   PubMed Web of Science ®Google Scholar
• Greten TF, Eigler A, Sinha B, Moeller J, Enders S. The specific type IV phosphodiesterase inhibitor rolipram differentially regulates the proinflammatory mediators TNF-alpha and nitric oxide. Int J Immunopharmacol 1995; 17(7):605–610.
   PubMed Web of Science ®Google Scholar
• Kim KO, Park SY, Han CW, Chung HK, Yoo DH, Han JS. Effect of sildenafil citrate on interleukin-1beta-induced nitric oxide synthesis and iNOS expression in SW982 cells. Exp Mol Med 2008; 40(3):286–293.
   PubMed Web of Science ®Google Scholar
• Wright CD, Kuipers PJ, Kobylarz-Singer D, Devall LJ, Klinkefus BA, Weishaar RE. Differential inhibition of human neutrophil functions. Role of cyclic AMP-specific, cyclic GMP-insensitive phosphodiesterase. Biochem Pharmacol 1990; 40(4):699–707.
   PubMed Web of Science ®Google Scholar